Prophylaxis of thromboembolic disease.
D000005:Abdomen / Q000601:surgery; D001241:Aspirin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003911:Dextrans / Q000009:adverse effects / Q000627:therapeutic use; D004311:Double-Blind Method; D004434:Early Ambulation; D006470:Hemorrhage / Q000139:chemically induced; D006493:Heparin / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007279:Injections, Subcutaneous; D008012:Lidocaine / Q000627:therapeutic use; D008297:Male; D009985:Orthopedics; D011183:Postoperative Complications / Q000517:prevention & control*; D011187:Posture; D011467:Prostate / Q000601:surgery; D013903:Thoracic Surgery; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control*; D014859:Warfarin / Q000627:therapeutic use
D003911:Dextrans; D014859:Warfarin; D006493:Heparin; D008012:Lidocaine; D001241:Aspirin